Our Health 25 Strategy spans disciplines, locations and industries to convert our research innovations into results that truly matter.
“The value of human endeavour is magnified when you bring together different view points and complementary expertise. It is only through our partnerships with industry, government and community that we will be able to tackle today’s global health challenges.”
Professor Phoebe Phillips, Associate Dean Partnerships and Engagement, UNSW Medicine and Health
The UNSW RNA Institute, Australia’s leading RNA science, therapeutics and translational facility, has officially opened. Established with a $25 million investment from UNSW Sydney as part of a NSW RNA Bioscience Alliance between NSW universities and the State Government, the Institute will build NSW’s capability to research, develop and manufacture RNA-based therapeutics locally.
UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the pancreatic cancer clinical trial program, thanks to a $3.75 million grant from the Cancer Institute NSW.
Partnerships magnify our ability to make a positive impact in medicine and healthcare. Under our Health 25 Strategy Partnerships has been identified as a pillar of our success as a faculty as we strive to improve health in Australia and globally – with a focus on eliminating health disparities and tackling the most difficult problems in medicine and public health. We know that we can make the biggest impact by working with others who are also excellent in their field.
Find out more about partnering with UNSW Medicine & Health.